Pharming Stock (NASDAQ:PHAR), Quotes and News Summary

Q: What sector and industry does Pharming (PHAR) operate in?

Pharming is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Pharming Stock (NASDAQ: PHAR) stock price, news, charts, stock research, profile.

Open	$9.691
Close	-
Volume / Avg.	524.000 / 2.684K
Day Range	9.691 - 9.691
52 Wk Range	9.270 - 16.710
Market Cap	$651.215M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	-
Days to Cover	1

Recent News

What's Going On With Netherlands-Based Biopharma Company Pharming Shares Today?

Pharming Group (NASDAQ: PHAR) updated its full-year 2023 guidance, including RUCONEST and Joenja revenues, and a progress update on the

Lekha Gupta

IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session.

Lisa Levin

Pitney Bowes, Marathon Digital And Other Big Stocks Moving Higher On Monday

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 80 points on Monday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Pharming Group N.V.

Sector

Health Care

Industry

Biotechnology

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pharming (PHAR) stock?

You can purchase shares of Pharming (NASDAQ: PHAR) through any online brokerage.

View our list of the best stock brokerages.

Who are Pharming's (PHAR) competitors?

Other companies in Pharming’s space includes: Cabaletta Bio (NASDAQ:CABA), ARS Pharmaceuticals (NASDAQ:SPRY), Cogent Biosciences (NASDAQ:COGT), Sage Therapeutics (NASDAQ:SAGE) and Tango Therapeutics (NASDAQ:TNGX).

What is the target price for Pharming (PHAR) stock?

The latest price target for Pharming (NASDAQ: PHAR) was reported by HC Wainwright & Co. on Thursday, March 14, 2024. The analyst firm set a price target for 37.00 expecting PHAR to rise to within 12 months (a possible 282.63% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Pharming (PHAR)?

The stock price for Pharming (NASDAQ: PHAR) is $9.67 last updated April 22, 2024 at 8:45 AM EDT.

Does Pharming (PHAR) pay a dividend?

There are no upcoming dividends for Pharming.

When is Pharming (NASDAQ:PHAR) reporting earnings?

Pharming’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Pharming (PHAR) going to split?

There is no upcoming split for Pharming.

What sector and industry does Pharming (PHAR) operate in?

Pharming is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-